We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00855972
Recruitment Status : Withdrawn (The FDA IND application is paused due to additional required testing. The IRB protocol was closed prior to research starting.)
First Posted : March 5, 2009
Last Update Posted : December 11, 2015
Information provided by (Responsible Party):
Sean Mackey, Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : December 2011
  Estimated Study Completion Date : December 2011